Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Tetanus toxoid

Inactivation with formaldehyde leads to non-toxic form of tetanus toxin.
 
ALX-630-108-C100 100 µg 812.00 USD
Do you need bulk/larger quantities?
 
Produced from tetanus toxin by inactivation with formaldehyde. The resulting toxoid is essentially non-toxic.

Product Specification

Alternative Name:Formaldehyde inactivated tetanus toxin
 
MW:~150kDa
 
UniProt ID:P04958
 
Concentration:0.5μg/μl after reconstitution.
 
Formulation:Lyophilized.
 
Purity:≥90% (SDS-PAGE)
 
Quality Control:Immunoprecipitation; concentration determination by UV absorbance.
 
Reconstitution:Reconstitute with 200μl distilled water to get a 0.5μg/μl solution in 100mM histidine, 100mM sodium chloride and 2% trehalose, pH 7.0.
 
Shipping:Ambient
 
Long Term Storage:+4°C
 
Use/Stability:Stock solutions are stable for up to 6 months when stored at -20°C.
 
Handling:Sealed under vacuum. Do not exceed one freeze/thaw cycle. Do not vortex. After reconstitution, prepare aliquots and store at -20°C.
 

Product Literature References

Tetanus vaccination with a dissolving microneedle patch confers protective immune responses in pregnancy: E. Esser, et al.; J. Control Release 236, 47 (2016), Application(s): ELISA for humoral immune responses, Abstract;
Molecular and functional characterization of allogantigen-specific anergic T cells suitable for cell therapy: R. Bacchetta, et al.; Haematologica 95, 2134 (2010), Abstract; Full Text
Triggering the succinate receptor GPR91 on dendritic cells enhances immunity: T. Rubic, et al.; Nat. Immunol. 9, 1261 (2008), Abstract;

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
Clostridium tetani
By biological activity:
Clostridium tetani Toxin
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,